APOBEC3缺失多态性对台湾胶质瘤患者的预后价值
该研究在台湾检测403例胶质瘤患者和1365名健康个体的APOBEC3缺失基因型,分析其与胶质瘤风险、临床病理因素、生存及性别的关系。结果显示APOBEC3B-/-和APOBEC3B+/-基因型在胶质母细胞瘤患者中比例更高,且在男性中与更高胶质母细胞瘤风险相关;APOBEC3B-/-与男性星形细胞胶质瘤患者更好的总生存相关,女性队列中未观察到基因型与风险及生存的显著相关性。
要点
- APOBEC3B-/-和+/-基因型在胶质母细胞瘤患者中比例高于健康个体,男性中与更高胶质母细胞瘤风险相关。
- 男性胶质瘤患者中APOBEC3B-比例高于女性患者。
- APOBEC3B-/-与男性星形细胞胶质瘤患者更好的总生存相关,女性队列中无显著相关性。
核心结论
- 生殖系APOBEC3缺失与台湾男性人群中胶质母细胞瘤风险增加及星形细胞胶质瘤患者更好总生存相关。
- APOBEC3B缺失纯合子可能是预测男性星形细胞胶质瘤患者更好生存的潜在独立预后因素。
研究设计与样本
- 检测台湾403例胶质瘤患者和1365名健康个体的APOBEC3缺失基因型。
- 将基因型与胶质瘤风险、临床病理因素、患者生存及性别进行关联分析。
- 检测APOBEC3基因家族表达并与生殖系缺失进行关联。
- 构建列线图模型预测胶质瘤患者生存。
主要发现
- APOBEC3B-/-和APOBEC3B+/-基因型在胶质母细胞瘤患者中比例高于健康个体,且在男性中与更高胶质母细胞瘤风险相关。
- 男性胶质瘤患者中APOBEC3B-病例比例高于女性患者。
- APOBEC3B-/-与男性星形细胞胶质瘤患者更好的总生存相关;女性患者队列中未观察到基因型与胶质瘤风险及生存的显著相关性。
- 星形细胞胶质瘤患者中APOBEC3B-/-者APOBEC3B表达更低,且与更好总生存正相关。
- 基于研究队列中男性星形细胞胶质瘤患者构建的5因素列线图模型可有效预测患者总生存。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The molecular pathogenesis of malignant gliomas, characterized by diverse tumor histology with differential prognosis, remains largely unelucidated. An APOBEC3 deletion polymorphism, with a deletion in APOBEC3B, has been correlated to risk and prognosis in several cancers, but its role in glioma is unclear. The authors aimed to examine the clinical relevance of the APOBEC3 deletion polymorphism to glioma risk and survival in a glioma patient cohort in Taiwan. METHODS: The authors detected deletion genotypes in 403 glioma patients and 1365 healthy individuals in Taiwan and correlated the genotypes with glioma risk, clinicopathological factors, patient survival, and patient sex. APOBEC3 gene family expression was measured and correlated to the germline deletion. A nomogram model was constructed to predict patient survival in glioma. RESULTS: The proportion of APOBEC3B-/- and APOBEC3B+/- genotypes was higher in glioblastoma (GBM) patients than healthy individuals and correlated with higher GBM risk in males. A higher percentage of cases with APOBEC3B- was observed in male than female glioma patients. The presence of APOBEC3B-/- was correlated with better overall survival (OS) in male astrocytic glioma patients. No significant correlation of the genotypes to glioma risk and survival was observed in the female patient cohort. Lower APOBEC3B expression was observed in astrocytic glioma patients with APOBEC3B-/- and was positively correlated with better OS. A 5-factor nomogram model was constructed based on male patients with astrocytic gliomas in the study cohort and worked efficiently for predicting patient OS. CONCLUSIONS: The germline APOBEC3 deletion was associated with increased GBM risk and better OS in astrocytic glioma patients in the Taiwan male population. The APOBEC3B deletion homozygote was a potential independent prognostic factor predicting better survival in male astrocytic glioma patients.
引用
- Chen CH, Wei KC, Liao WC, et al. Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan. J Neurosurg. 2022. PMID: 36152319. doi:10.3171/2022.7.JNS2250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。